A Phase 1/2 Study of SL-701, A Subcutaneously Injected M

Project: Research project

Project Details

Description

A Phase 1/2 Study of SL-701, A Subcutaneously Injected Multivalent Glioma-Associated Antigen Vaccine, in Adult Patients with Recurrent Glioblastoma Multiforme
StatusFinished
Effective start/end date5/1/145/30/19

Funding

  • STEMLINE THERAPEUTICS, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.